Breathing breakthrough? hormone tested for critical lung failure
NCT ID NCT04115514
Summary
This study is testing whether delivering a thyroid hormone (T3) directly into the lungs is safe and can help patients with Acute Respiratory Distress Syndrome (ARDS) breathe better. It will involve 68 critically ill adults on breathing machines. Researchers will give the hormone through a breathing tube twice daily for up to five days to see if it improves oxygen levels in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS, HUMAN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
East Bank Hospital - M Health Fairview University of Minnesota Medical Center
RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact
-
M Health Fairview Southdale Hospital
RECRUITINGEdina, Minnesota, 55435, United States
Contact
Conditions
Explore the condition pages connected to this study.